These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1414943)

  • 1. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study).
    Lauer MS; Evans JC; Levy D
    Am J Cardiol; 1992 Nov; 70(13):1180-4. PubMed ID: 1414943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of left ventricular dilatation and hypertrophy with chronotropic incompetence in the Framingham Heart Study.
    Lauer MS; Larson MG; Evans JC; Levy D
    Am Heart J; 1999 May; 137(5):903-9. PubMed ID: 10220640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study).
    Galderisi M; Lauer MS; Levy D
    Am J Cardiol; 1992 Oct; 70(11):971-6. PubMed ID: 1414914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function.
    Aleong RG; Mulvahill MJ; Halder I; Carlson NE; Singh M; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Gutmann R; Sauer WH; Narayanan K; Chugh SS; Saba S; London B
    J Am Heart Assoc; 2015 Jul; 4(8):e001566. PubMed ID: 26231842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive Prognostic Value of Left Ventricular Systolic Dysfunction in a Population-Based Cohort.
    Kuznetsova T; Cauwenberghs N; Knez J; Yang WY; Herbots L; D'hooge J; Haddad F; Thijs L; Voigt JU; Staessen JA
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27329778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial dilatation and ST-T changes predict cardiovascular outcome in chronic hemodialysis patients.
    Omae K; Ogawa T; Yoshikawa M; Nitta K
    Heart Vessels; 2012 Nov; 27(6):610-7. PubMed ID: 21953505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of regression of left ventricular hypertrophy from systemic hypertension on systolic function assessed by midwall shortening (HOT echocardiographic study).
    Zabalgoitia M; Rahman SN; Haley WE; Yarows S; Krause L; Anderson LC; Oraby MA; Amarena J
    Am J Cardiol; 2001 Sep; 88(5):521-5. PubMed ID: 11524061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Abnormalities in Echocardiographic Parameters and Risk of Sudden Cardiac Death in a General Population: The Rotterdam Study.
    Niemeijer MN; Leening MJ; van den Berg ME; Hofman A; Franco OH; Deckers JW; Rijnbeek PR; Stricker BH; Eijgelsheim M
    J Card Fail; 2016 Jan; 22(1):17-23. PubMed ID: 26093333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.
    Vasan RS; Larson MG; Benjamin EJ; Evans JC; Levy D
    N Engl J Med; 1997 May; 336(19):1350-5. PubMed ID: 9134875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
    Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
    J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
    Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of LV Strain Risk Score in Asymptomatic Patients With Hypertensive Heart Disease.
    Saito M; Khan F; Stoklosa T; Iannaccone A; Negishi K; Marwick TH
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):911-21. PubMed ID: 27344417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of left ventricular systolic function using midwall mechanics in patients >60 years of age with hypertensive heart disease and heart failure.
    Vinch CS; Aurigemma GP; Simon HU; Hill JC; Tighe DA; Meyer TE
    Am J Cardiol; 2005 Nov; 96(9):1299-303. PubMed ID: 16253602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: a tissue Doppler study in echocardiographic practice.
    Cuspidi C; Negri F; Sala C; Valerio C; Mancia G
    Blood Press; 2012 Feb; 21(1):24-30. PubMed ID: 21992028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study.
    Gardin JM; Siscovick D; Anton-Culver H; Lynch JC; Smith VE; Klopfenstein HS; Bommer WJ; Fried L; O'Leary D; Manolio TA
    Circulation; 1995 Mar; 91(6):1739-48. PubMed ID: 7882482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
    Gerdts E; Zabalgoitia M; Björnstad H; Svendsen TL; Devereux RB
    Am J Cardiol; 2001 Apr; 87(8):980-3; A4. PubMed ID: 11305990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study).
    Halland H; Lønnebakken MT; Pristaj N; Saeed S; Midtbø H; Einarsen E; Gerdts E
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1054-1060. PubMed ID: 30177273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study.
    Wachtell K; Gerdts E; Palmieri V; Olsen MH; Nieminen MS; Papademetriou V; Boman K; Dahlöf B; Aurigemma GP; Rokkedal JE; Devereux RB
    J Hypertens; 2010 Jul; 28(7):1541-6. PubMed ID: 20410835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.